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results in only 44%, 40%, 31%, 28% and 20% of the variance of 
tumor motion being explained by local rectum motion for 
respectively ProximateRectums of 1, 3, 5, 7 and 10 mm. 
 
Conclusion: Even when the rectal motion surrogate is 
defined within 1 mm of the tumor, tracking this part of the 
rectal wall will not result in an accurate tumor positions 
since only 44% of the variance in tumor motion is explained 
by tracking the rectal wall. The lack of anatomical landmarks 
prevents finding the true rectum deformation and thus an 
accurate tumor position. Especially for motion in cranial-
caudal direction, there is poor correlation between tumor 
and local rectal motion. Therefore, anatomical landmarks are 
needed for positioning the tumor e.g. direct imaging of the 
tumor using MRI or indirect imaging of the tumor using 
implanted markers. 
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Purpose or Objective: In cervical cancer, adaptive radiation 
therapy (ART) can be applied to compensate for interfraction 
target motion. However, organs at risk (OAR) still receive 
substantial dose when photon-based ART is applied. Adaptive 
proton therapy (APT) holds the promise to further limit OAR 
dose while maintaining adequate target coverage. Our aim 
was to investigate the potential dosimetric advantages of 
image-guided APT (IGAPT) compared with photon-based 
image-guided ART (IGART). 
 
Material and Methods: Twelve cervical cancer patients 
treated with photon therapy were included in this 
retrospective study. Besides the clinically acquired full 
bladder planning CT, additional empty bladder planning CT 
and weekly repeat CTs were acquired for study purposes. 
Planning CTs were registered based on bony anatomy and 
multiple interpolated cervix-uterus structures were derived 
using a point-based non-rigid registration method. For each 
interpolated structure, a photon (VMAT) and a proton (IMPT) 
plan was created to build patient-specific plan libraries. All 
plans were robustly optimized with a prescribed physical CTV 
dose of 46 Gy-equivalent (GyE) (23 x 2 GyE) for pelvic 
irradiation or 50.4 GyE (28 x 1.8 GyE) for para-aortic 
irradiation. For each patient, repeat CTs were registered to 
the full bladder planning CT based on bony anatomy and 
IGART and IGAPT treatments were simulated by selecting 
library plans and recalculating the dose. For each simulated 
fraction, CTV coverage (V95% > 98%) was assessed and 
differences in Dmean and D2cc fraction dose and fractionated 
substitutes of V15Gy, V30Gy and V45Gy parameters (i.e. dose 
levels divided by the number of fractions) for bladder, bowel 
and rectum were evaluated and tested for significance 
(Wilcoxon signed-rank test). Also, fraction dose distributions 
were accumulated and differences in the overall rectum 
toxicity related DVH parameter (V30Gy) and normal tissue 
complication probability (NTCP) for grade 2 acute 
gastrointestinal toxicity were determined. 
 
Results: In 6 fractions (10.7%), the cervix-uterus structure 
deviated substantially from the pre-treatment derived 
structures. Adequate CTV coverage was obtained in 92% (96%) 
of the remaining fractions for IGAPT (IGART) which resulted 
in adequate CTV coverage on average per patient. All DVH 
parameters for bladder, bowel and rectum, except for the 
fractionated substitute of rectum V45Gy, were improved 
using IGAPT (Figure). Also, the mean dose to bowel, bladder 
and rectum was reduced significantly (p<0.01). Compared to 
IGART, IGAPT indicated a mean reduction of 7% for rectum 
V30Gy and a mean decrease from 0.33 to 0.18 in bowel 
NTCP. 
 
 
 
Conclusion: This study demonstrates the feasibility of IGAPT 
in cervical cancer using a plan library based adaptive strategy 
to compensate for interfraction target motion. Compared to 
photon-based IGART, IGAPT maintains adequate target 
coverage while a significant dose reduction in bladder, bowel 
and rectum can be achieved. 
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Purpose or Objective: The retrospective analysis of 
anonymous data investigates the benefit of predictive 
analysis to assess anatomical and dosimetric variations for 
Adaptive Radiation Therapy (ART) purpose. Within a 
multicenter research network, clinical outcome were 
evaluated to determinate eligible patients for re-planning; a 
time series analysis allows scheduling re-planning during RT. 
We highlighted advantage and challenges due to the 
combination of IGRT (MVCT and CBCT), deformable image 
registration (DIR) and different set-up protocols comparing 
the multicenter data.  
 
Material and Methods: The retrospective study enrolled 40 
head and neck (H&N) anonymous patients from Center-A 
(MVCT), 20 from Center-B (CBCT), 8 from Center-C (CBCT), 8 
from Center-D (CBCT). We have post-processed more than 
2100 CT studies obtained by the imaging on board (>200000 
slices). We analyzed parotid gland (PG) such as organs most 
affected by warping during the weeks of therapy. Volume and 
dose were normalized to the first day of treatment in order 
to remove bias related to machine/images variability and 
anatomical dimension. Structures were re-contoured 
automatically and the doses deformation was performed by 
RayStation® within an automated ART workflow supported by 
IronPython® scripting. Using DIR algorithms and GPU fast 
computing, the daily setup images were analyzed and 
compared. To support the data-mining; a Neural Network 
(NN) tool was developed and implemented in MATLAB® to 
evaluate abnormal clinical cases and re-planning strategies 
during fractions. 
 
Results: A weekly analysis was carried out to follow and 
predict variations. After 6 weeks of therapy, PG showed a 
mean volume decrease of 23.7±8.8%: 25.1±9.2% in Center-A, 
23.8±6.6% in Center-B, 21.2±10.3% in Center-C, 24.4±9.8% in 
Center-D. The NN analysis showed that, during the first 3 
weeks, almost the patients’ cohort followed a similar trend. 
Mean PG morphing can be predictable in 86.3% of the center 
cases: 89.6% A, 92.7% B, 76.0% C, 87.0% D. From the 4th 
week some challenges appeared. The patients that benefit 
from a review of the initial plan increased during treatment, 
highlighting the need of re-planning. Based on PG shrinkage, 
53.5% of patients would need a re-planning with an inter-
centers variability of 19.7%. An amount of 17.0% of cases is 
affected by bias due to algorithm and set-up error: 11.5% and 
5.5% respectively. 
 
 
 
 
Conclusion: IGRT and ART techniques ensure a 
personalization of patients’ treatment. A predictive NN tool 
was implemented and trained in order to detect criticalities 
in a multi-centric study supporting the feasibility of national 
data-mining for ART purpose. Based on PG warping and data 
prediction, a mid-course re-planning could be scheduled in 
the 4th week to ensure an adequate dose distribution during 
the treatment course. 
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Purpose or Objective: Cone beam CT (CBCT) based dose 
calculations are inaccurate due to the image quality of CBCT 
images acquired for image guided radiation therapy (IGRT). 
This study demonstrates that a post-processing of the raw 
projection data can improve the CBCT image quality such 
that the accuracy of CBCT based dose calculations can be 
recovered. 
 
Material and Methods: 5 lung cancer patients were selected 
for analysis, all of whom had a re-simulation CT (rCT) scan 
performed on the same day as a CBCT scan during their 
radiotherapy treatment. For each patient, two CBCT 
reconstructions were computed and used for dose 
calculation. The first CBCT was a clinical 3D reconstruction of 
the CBCT images as acquired for IGRT by the Elekta XVI R4.5 
system (denoted cCBCT). The second CBCT used the clinical 
projection images, but was corrected for image lag, detector 
scatter, body scatter, beam hardening, and truncation 
artefacts prior to reconstruction using the open-source 
Reconstruction Toolkit. This second reconstruction is denoted 
iCBCT. 
Although the rCT and CBCT images were acquired on the 
same day, setup errors and anatomical differences such as 
diaphragm and chest wall position were evident when the 
CBCT images were compared with the rCT. Therefore, 
deformable image registration was performed with elastix, to 
eliminate dose differences due to anatomical differences 
between the scans. Missing anatomy in the CBCT images due 
to the limited field of view was copied from the rCT image 
after deformable registration of the CBCT images. 
The original treatment plan was recalculated on the rCT, 
cCBCT, and iCBCT image sets using Pinnacle ver. 9.10. The 
resulting dose matrices were compared using a 2%/2mm and 
1%/1mm gamma analysis with the rCT dose as reference 
dose. The dose criterion was evaluated as 2% (1%) of the 
prescribed dose of 66 Gy. A low dose threshold of 10% of the 
prescription dose was used, and the gamma analysis was only 
performed in the CBCT volume. 
